Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis.

about

Can diffusion-weighted imaging predict tumor grade and expression of Ki-67 in breast cancer? A multicenter analysis.

P2860

Q55286708-812CCDB1-38FA-43B8-87CD-42DB135E2766

P2860

Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis.

Item

http://www.wikidata.org/entity/Q49486164

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ki-67 labeling index is a pred ...... reast cancer: A meta-analysis.

@en

Ki-67 labeling index is a pred ...... reast cancer: A meta-analysis.

@nl

type

Item

label

Ki-67 labeling index is a pred ...... reast cancer: A meta-analysis.

@en

Ki-67 labeling index is a pred ...... reast cancer: A meta-analysis.

@nl

prefLabel

Ki-67 labeling index is a pred ...... reast cancer: A meta-analysis.

@en

Ki-67 labeling index is a pred ...... reast cancer: A meta-analysis.

@nl

P1476

Ki-67 labeling index is a pred ...... reast cancer: A meta-analysis.

@en

P2093

Miaomiao Tao

http://www.w3.org/2001/XMLSchema#string

Qi Zhou

http://www.w3.org/2001/XMLSchema#string

Shu Chen

http://www.w3.org/2001/XMLSchema#string

Xianquan Zhang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NoDerivs 4.0 International

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Cancer statistics, 2016

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment.

Preoperative (neoadjuvant) chemotherapy in patients with breast cancer.

Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.

Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Can ki-67 play a role in prediction of breast cancer patients' response to neoadjuvant chemotherapy?

Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer.

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis.

P304

e9384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.1097/MD.0000000000009384

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29390540

http://www.w3.org/2001/XMLSchema#string

P921

P932

5758242

http://www.w3.org/2001/XMLSchema#string

Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis.

about

P2860

P2860

Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P433

P478

P5008

P577

P698

P921

P932